These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622 [TBL] [Abstract][Full Text] [Related]
3. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients. Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile? Balduyck B; Trousse D; Nakas A; Martin-Ucar AE; Edwards J; Waller DA Ann Thorac Surg; 2010 Mar; 89(3):907-11. PubMed ID: 20172152 [TBL] [Abstract][Full Text] [Related]
5. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. Neragi-Miandoab S; Richards WG; Sugarbaker DJ Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and survival in malignant pleural mesothelioma. Van Gelder T; Damhuis RA; Hoogsteden HC Eur Respir J; 1994 Jun; 7(6):1035-8. PubMed ID: 7925870 [TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. Edwards JG; Swinson DE; Jones JL; Muller S; Waller DA; O'Byrne KJ Chest; 2003 Nov; 124(5):1916-23. PubMed ID: 14605068 [TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis. Baud M; Strano S; Dechartres A; Jouni R; Triponez F; Chouaid C; Forgez P; Damotte D; Roche N; Régnard JF; Alifano M J Thorac Cardiovasc Surg; 2013 May; 145(5):1305-11. PubMed ID: 23072703 [TBL] [Abstract][Full Text] [Related]
10. Re-evaluating the role of palliative radiotherapy in malignant pleural mesothelioma. Jenkins P; Milliner R; Salmon C Eur J Cancer; 2011 Sep; 47(14):2143-9. PubMed ID: 21658936 [TBL] [Abstract][Full Text] [Related]
11. Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma. Yan TD; Boyer M; Tin MM; Sim J; Kennedy C; McLean J; Bannon PG; McCaughan BC Ann Thorac Surg; 2009 May; 87(5):1552-6. PubMed ID: 19379903 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma. Demirag F; Unsal E; Yilmaz A; Caglar A Chest; 2005 Nov; 128(5):3382-7. PubMed ID: 16304288 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors according to the treatment schedule in malignant pleural mesothelioma. Ak G; Metintas S; Metintas M; Yildirim H; Erginel S; Kurt E; Alatas F; Cadirci O J Thorac Oncol; 2009 Nov; 4(11):1425-30. PubMed ID: 19752758 [TBL] [Abstract][Full Text] [Related]
14. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma? Zahid I; Sharif S; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma. Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for 100 patients with malignant pleural mesothelioma. Gonlugur U; Gonlugur TE Arch Environ Occup Health; 2010; 65(2):65-9. PubMed ID: 20439224 [TBL] [Abstract][Full Text] [Related]
17. Pemetrexed in malignant pleural mesothelioma and the clinical outcome. Knuuttila A; Salomaa ER; Saikkonen S; Hurme S; Salo J Clin Respir J; 2012 Apr; 6(2):96-103. PubMed ID: 21651743 [TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma: surgical management in 285 patients. Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820 [TBL] [Abstract][Full Text] [Related]
19. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Burt BM; Rodig SJ; Tilleman TR; Elbardissi AW; Bueno R; Sugarbaker DJ Cancer; 2011 Nov; 117(22):5234-44. PubMed ID: 21523763 [TBL] [Abstract][Full Text] [Related]
20. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]